Evidence map›Paper›PMID 40828855›Full record

ArticlePLoS computational biology2025

Assessing variant effect predictors and disease mechanisms in intrinsically disordered proteins.

Mohamed Fawzy, Joseph A Marsh

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohamed FawzyMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-4132-0628

Funding

European Union's Horizon 2020 research and innovation programmeMedical Research Council (MRC) MC_UU_00035/9
6 · The paper itself

Abstract

Intrinsically disordered regions (IDRs) are central to diverse cellular processes but present unique challenges for interpreting genetic variants implicated in human disease. Unlike structured protein domains, IDRs lack stable three-dimensional conformations and are often involved in regulation through transient interactions and post-translational modifications. These features can affect both the distribution of pathogenic variants and the performance of computational tools used to predict their effects. Here, we systematically assessed the distribution of pathogenic vs benign missense variants across disordered, intermediate, and structured protein regions in the human proteome. Pathogenic variants were notably depleted in IDRs yet were associated with distinct molecular mechanisms, particularly dominant gain- and loss-of-function effects. We evaluated 33 variant effect predictors (VEPs), revealing widespread reductions in sensitivity for pathogenic variants in IDRs, despite high AUROC scores driven by accurate benign variant predictions. We also observed substantial discordance among VEP classifications in disordered regions, underscoring the need for region-aware thresholds and disorder-informed prediction strategies. Incorporating features reflective of IDR biology, such as transient interaction motifs and modification sites, may enhance the accuracy and interpretability of future tools.

Indexed as

Intrinsically Disordered ProteinsComputational BiologyGenetic Predisposition to DiseaseGenetic VariationHumansMutation, MissenseProtein ConformationProteomeIntrinsically Disordered ProteinsProteome

Identifiers

PMID40828855
PMCPMC12377588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.